top of page
kirabio-hero-4.png

Pipeline

kirabio-hero-1.jpg

Programmable Cell Therapies for the Toughest Cancers

​

We engineer multiplex-edited, off-the-shelf cell therapies that ignore suppressive TME signals and keep working where others fade. First stop: GBM.

 

KiraLOGIC guides edit selection based on the dominant suppressive signals in each disease, ensuring our designs are precision-built for TME resistance.

Pipeline-2.png

*All programs use an allogeneic chassis and are optimized for TME resistance.

More than a pipeline — a blueprint for durable cell therapies that overcome immune suppression.

bottom of page